BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment
Clinical trial NCT03789019 · COMPLETED
Trial details
- NCT number
- NCT03789019
- Sponsor
- Meabco A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-22
- Primary completion
- 2016-07-29
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.